Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer

Fluoropyrimidines, oxaliplatin, irinotecan and biologic therapies (Bevacizumab, Panitumumab, and Cetuximab) represent the backbone of metastatic colorectal cancer (CRC) treatment. The improvement in survival for mCRC patient led to two main outstanding issues: 1) there is a significant number of pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Tonini, Giuseppe, Imperatori, Marco, Vincenzi, Bruno, Frezza, Anna Maria, Santini, Daniele
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874688/
https://ncbi.nlm.nih.gov/pubmed/24245912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-92
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items